Veille Scientifique

Patrice PIENKOWSKI
Coordinateur

 Après 3 ans de bons et loyaux services, la veille scientifique va s’arrêter ; voici les derniers articles sélectionnés à votre intention.
 
Nous avons pris cette décision difficile suite au constat d’un investissement très important pour un service rendu finalement incertain, comme l’attestent les statistiques de fréquentation de la rubrique sur ce site. 
 
Je remercie tous ceux et celles qui se sont investis dans la durée pour assurer la réussite du projet, à commencer par les responsables des groupes de veille : Emmanuel Coron (Endoscopie), Roger Faroux (Cancérologie), Pauline Jouët (Gastro-entérologie et proctologie), Stéphane Nahon (MICI), Vinciane Rebours (Pancréatologoie) et Christine Silvain (Hépatologie), mais aussi et surtout, tous les veilleurs anonymes pour la grande qualité de leur travail, leur compétence et leur persévérance.
Le travail de veille bibliographique ne disparait pas complètement malgré tout, grâce aux GastroScoops dont la fréquence va augmenter avec un objectif de diffusion hebdomadaire ; il s’agit d’un travail rédactionnel différent avec une analyse d’article plus approfondie et structurée, porteur de message important.

Restez donc fidèles à ces rubriques et visitez régulièrement le site de la SNFGE toujours très riche d’enseignements et d’informations.

Très cordialement.

Dr Patrice PIENKOWSKI

 

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
P. DUKAN
N. GANNE-CARRIE
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
T. HIGUERO
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
P. SEKSIK

M. CAMUS-DUBOC
E. GELSI
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revuetrier par ordre croissant Titre Date Coup de coeur Thématique
Clinical Gastroenterology and Hepatology Risk of Pancreatic Cancer in Patients With Pancreatic Cysts and Family History of Pancreatic Cancer juil. 18 3 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression juin. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti–Tumor Necrosis Factor Therapy for Crohn’s Disease: A Meta-analysis of Placebo-controlled Trials déc. 15 3 ♥ MICI
Clinical Gastroenterology and Hepatology Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Colonic MicroRNA Profiles, Identified by a Deep Learning Algorithm, That Predict Responses to Therapy of Patients With Acute Severe Ulcerative Colitis avr. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis. aoû. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed oct. 17 2 ♥ MICI
Clinical Gastroenterology and Hepatology Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease aoû. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission fév. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features sep. 18 3 ♥ Pancréas/Voies biliaires
Clinical Gastroenterology and Hepatology Incidence and Prevalence of Crohn’s Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010 juin. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis Jan. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology High Prevalence of Anal Canal High-Risk Human Papillomavirus Infection in Patients With Crohn's Disease. nov. 18 4 ♥ Coloproctologie
Clinical Gastroenterology and Hepatology Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis. avr. 19 3 ♥ MICI
Clinical Gastroenterology and Hepatology Outcomes of Endoscopic Balloon Dilation vs Surgical Resection for Primary Ileocolic Strictures in Patients With Crohn's Disease. aoû. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Cumulative Length of Bowel Resection in a Population-Based Cohort of Patients With Crohn's Disease oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Cesarean Section Delivery Is Not a Risk Factor for Development of Inflammatory Bowel Disease: A Population-based Analysis. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Intestinal Dilation and Platelet:Albumin Ratio Are Predictors of Surgery in Stricturing Small Bowel Crohn's Disease aoû. 16 3 ♥ MICI, Chirurgie
Clinical Gastroenterology and Hepatology Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-Based vs Trough Concentration-Based Dosing of Infliximab. aoû. 18 3 ♥ MICI
Clinical Gastroenterology and Hepatology Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. oct. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis fév. 17 3 ♥ MICI
Clinical Gastroenterology and Hepatology Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease nov. 16 3 ♥ MICI

Pages